Collaboration Between Mohs and Surgical Subspecialists in the Treatment of Advanced Nonmelanoma Skin Cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42437731.
- Also identified by DOI 10.1002/hed.70389.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Locally advanced and metastatic nonmelanoma skin cancers are frequently managed with operating room (OR)-based resection, lacking real-time margin assessment. Mohs micrographic surgery provides immediate margin evaluation but is limited in deeply invasive or metastatic disease. A coordinated approach combines the strengths of both strategies. Retrospective cohort study of patients with locally advanced tumors, with or without regional metastases, treated with Mohs surgery followed by OR resection. Twenty-one patients had median follow-up of 30 (IQR, 14-87) weeks. Mohs cleared the peripheral margin in all cases and the deep margin in 11 (52%) cases. Ten (48%) cases required OR resection of the deep margin, and 10 (48%) required resection of metastatic disease. Median time between surgeries was 2 (IQR, 1-16) days. Three patients (14%) developed recurrence. No disease-specific deaths occurred. Coordinating Mohs surgery with OR resection enables full margin assessment, surgical clearance of extensive disease, and immediate reconstruction.